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Abstract: 
Abstract  
 
Background: Psychiatric disorders are known to be prevalent in Multiple 
Sclerosis (MS).  
 
Objective: To study comorbidity between MS and bipolar disorder, 
schizophrenia and depression in a nation-wide cohort and to determine 
whether shared genetic liability underlies the putative association.  
 
Methods: We identified ICD-diagnosed patients with MS (n=16,467), 
bipolar disorder (n=30,761), schizophrenia (n= 22,781) and depression 
(n=172,479) in the Swedish National Patient Register and identified their 
siblings in the Multi-Generation Register. The risk of MS was compared in 
psychiatric patients and in matched unexposed individuals. Shared familial 
risk between MS and psychiatric disorders was estimated by sibling 
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comparison.  
 
Results: The risk of MS was increased in patients with bipolar disorder 
(hazard ratio [HR] 1.8, 95% confidence interval [CI] 1.6-2.2, p<0.0001) 
and depression (HR 1.9, 95% CI 1.7-2.0, p<0.0001). MS risk in 
schizophrenia was decreased (HR 0.6, 95% CI 0.4-0.9, p=0.005). The 
association between having a sibling with a psychiatric disorder and 
developing MS was not significant.  
 
Conclusion: We found a strong positive association between MS and bipolar 
disorder and depression that could not be explained by genetic liability. 
The unexpected negative association between MS and schizophrenia might 
be spurious or indicate possible protective mechanisms that warrant 
further exploration.  
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Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide 
Swedish cohort 
 
Abstract 
Background: Psychiatric disorders are known to be prevalent in Multiple Sclerosis (MS).  
Objective: To study comorbidity between MS and bipolar disorder, schizophrenia and depression 
in a nation-wide cohort and to determine whether shared genetic liability underlies the putative 
association. 
Methods: We identified ICD-diagnosed patients with MS (n=16,467), bipolar disorder 
(n=30,761), schizophrenia (n= 22,781) and depression (n=172,479) in the Swedish National 
Patient Register and identified their siblings in the Multi-Generation Register. The risk of MS was 
compared in psychiatric patients and in matched unexposed individuals. Shared familial risk 
between MS and psychiatric disorders was estimated by sibling comparison. 
Results: The risk of MS was increased in patients with bipolar disorder (hazard ratio [HR] 1.8, 
95% confidence interval [CI] 1.6-2.2, p<0.0001) and depression (HR 1.9, 95% CI 1.7-2.0, 
p<0.0001). MS risk in schizophrenia was decreased (HR 0.6, 95% CI 0.4-0.9, p=0.005). The 
association between having a sibling with a psychiatric disorder and developing MS was not 
significant. 
Conclusion: We found a strong positive association between MS and bipolar disorder and 
depression that could not be explained by genetic liability. The unexpected negative association 
between MS and schizophrenia might be spurious or indicate possible protective mechanisms that 
warrant further exploration. 
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Introduction 
 
Multiple sclerosis (MS) is an inflammatory autoimmune disease resulting in demyelination and 
axonal loss of the central nervous system (CNS), which lead to disability with detrimental effects 
on quality of life (1). Emerging evidence suggests that inflammation also plays an important role in 
psychiatric disorders such as bipolar disorder, schizophrenia and depression (2). Several studies 
have shown increased rates of depression and bipolar disorder in patients with MS (3-14). In some 
studies, MS has also been associated with an increased risk of schizophrenia and non-affective 
psychosis (11, 15-17), while in other studies no association was demonstrated (14, 18). 
 
The association between MS and these psychiatric disorders might be explained by shared familial 
liability. Family, twin and adoption studies in MS, as well as in bipolar disorder, depression and 
schizophrenia, indicate moderate to high degrees of genetic influence; and moderate to high 
genetic correlations have been observed between the psychiatric diagnoses (19-21). In a 
population-based cohort study of parents and siblings to MS patients, an increased risk of 
schizophrenia, but not bipolar disorder, was found (7, 17), and in another study depression was not 
more common in first-degree relatives of MS patients (n=221) than in unexposed individuals (10). 
 
Some of these previous studies have had limited statistical power due to modestly sized data sets 
(10), while others have arrived at contradictory results with regard to non-affective psychosis and 
schizophrenia (11, 14-18) or failed to report risks for matched population controls. Here, with a 
view to studying the relationship between MS and bipolar disorder, schizophrenia and depression, 
we sought to overcome these limitations by using a Swedish national database, which constitutes, 
to our knowledge, the largest cohort ever employed for this purpose. In addition, we used a 
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matched cohort sibling design to investigate whether shared genetic liability might underlie the 
putative comorbidity between MS and the psychiatric disorders. 
 
Materials and Methods 
 
Data sources 
The study was approved by the ethics committee of Karolinska Institutet. The Swedish National 
Patient Register (NPR, National Board of Health and Welfare, http://www.socialstyrelsen.se) is a 
nationwide register containing information on inpatient care (psychiatric diagnoses from 1973 and 
MS from 1987) and specialist care (from 2001). It has a high level of agreement with medical and 
psychiatric diagnoses (22). The Swedish MS Register (SMSreg; http:/www.msreg.net) was started 
in 1996 and includes information on 13,558 unique individuals registered prior to January 1, 2010; 
MS diagnosis are decided by consultant neurologists (23). The Swedish Multi-Generation Register 
(Statistics Sweden, http://www.scb.se) is a national database with coverage of individuals born in 
Sweden since 1932 and living in Sweden after 1960, and of immigrants who became Swedish 
citizens before the age of 18. The Cause of Death Register (National Board of Health and Welfare) 
provides data regarding all deaths, and the Total Population Register (Statistics Sweden) contains 
information on immigration and emigration from the country. 
 
Disease classification 
Using codes from the International Classification of Diseases (ICD 8-10), we identified in the NPR 
patients diagnosed with bipolar disorder, schizoaffective disorder, schizophrenia, depression and 
MS (Table 1). We identified a subgroup of patients with bipolar disorder who had experienced one 
or more episodes of mania (designated bipolar disorder type I), and a subgroup of subjects with 
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depression who had experienced at least one episode of severe depression (designated severe 
depression). A validation study of the bipolar diagnosis in the NPR found that two independent 
inpatient admissions generated a positive predictive value of 0.81 (24). A requirement of two 
diagnoses to define schizophrenia resulted in frequencies comparable to internationally reported 
lifetime prevalence percentages (25). To secure diagnostic specificity, we required two or more 
diagnoses from the NPR for all diagnostic categories. To differentiate between bipolar disorder, 
schizophrenia and schizoaffective disorder, we did not allow any overlap between the three 
diagnoses, and subjects with more than one of these diagnoses were classified in a separate mixed 
category (designated mixed bipolar/psychosis). 
 
We used the SMSreg to verify the quality of the MS diagnoses from the NPR where individuals are 
coded as having MS according to the McDonald criteria (26). 96% of the patients with a diagnosis 
of MS in the NPR were registered as having MS in the SMSreg. 
 
Study population and design 
To study associations between psychiatric disorders and MS, we used a matched cohort design 
based on individuals and pairs of siblings living in Sweden, whom we had identified from, register 
linkages with the help of the unique personal identification number assigned to each Swedish 
resident.  
 
In a “comorbidity cohort” we assessed the association between a psychiatric diagnosis (exposure 
directly to the particular disorder) and risk of MS (outcome), and in a “sibling cohort” (familial 
analysis) we assessed the association between having a sibling with a psychiatric disorder 
(exposure to an inherited or environmentally mediated liability to the particular disorder) and risk 
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of MS (outcome; Figure 1). In the comorbidity cohort, we identified the exposed patients and 10 
randomly selected unexposed individuals per patient, matched by birth year and sex. Unexposed 
individuals had not received an exposure diagnosis prior to the date of the patient’s first diagnosis 
or start of follow-up, if it occurred later. In the sibling cohort all pairwise combinations of sibling 
pairs were considered. For each sibling pair exposed to the disorder of interest, we randomly 
selected 10 unexposed sibling pairs, matched for birth year and sex (for both individuals in the 
pair). The index person of the selected unexposed pairs was required to be alive, living in Sweden 
and free of the diagnosis of the exposed index person at the start of follow-up. 
 
The analyses were also performed in reverse order, to assess the association between MS or having 
a sibling with MS (exposure) and the risk of a psychiatric disorder (outcome; Figure 2). 
 
Analysis by time period 
To address the influence of ascertainment bias in the comorbidity analysis, we analyzed the risk of 
MS in three different time windows, as in Figure 3 and an alternative analysis, as in Figure 4. 
 
Sensitivity analysis 
To test the sensitivity of our results, we performed several additional analyses; patients with 
schizophrenia were analyzed without exclusion of cases with additional diagnoses of 
schizoaffective or bipolar disorder; individuals born between 1969 and 1991 were analyzed 
separately; the data was re-analyzed, with MS as exposure and the start of follow-up as 2001; the 
depression cohort was reanalyzed including patients with single diagnosis of depression; to assure 
the accuracy of the MS diagnoses, we analyzed the data using diagnostic information first from the 
SMSreg alone and then in combination with diagnostic information from the NPR. 
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Statistical analysis 
Descriptive statistics are presented as means and standard deviations for continuous data and 
frequencies and percentages for categorical data. Estimates for the risk of being diagnosed with an 
event among exposed individuals were obtained by calculating hazard ratios (HR) with 95% 
confidence intervals (CI) by a Cox regression model using SAS version 9.3. To compensate for the 
clustering effect in the sibling analysis, we used robust sandwich estimates. Follow-up started in 
1987 (or age 18) when MS was the event and in 1973 (or age 18) when psychiatric disorder was the 
event. Subjects were followed until an event occurred or until the subject was censored due to 
death, emigration or end of follow-up on December 31, 2009. Two-tailed probability values were 
calculated, with values less than 0.05 regarded as significant. In both the comorbidity and the 
sibling analyses, we adjusted for immigration status (born in or born outside of Sweden); effect 
modification was tested for by including interaction terms between sex and exposure. 
 
Results 
 
We identified 8,193,579 individuals born between 1932 and 1991 who were alive and residing in 
Sweden at the start of follow-up, Table 2. 
 
Comorbidity cohort—analysis of psychiatric disorders and MS 
We found a statistically significantly increased risk of MS in the patients with bipolar disorder as 
well as in the subcategory classified as bipolar disorder type I, Figure 5. In patients with 
schizophrenia, the risk of MS was significantly decreased. In schizoaffective disorder, MS risk was 
non-significantly decreased, whereas the risk in the mixed category did not differ from that of 
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unexposed subjects. In individuals with depression, MS risk was increased and the results 
remained significant in the subgroup of severely depressed patients. Adjustment for immigration 
status did not change the overall results. There was no evidence of sex-specific effects except for in 
bipolar disorder type I where the risk of MS was increased in males compared to females 
(interaction effect p=0.0008), Table 3. The results were similar when the risk of psychiatric 
disorders in the cohort of MS patients was analyzed, Table 4. 
 
Comorbidity cohort—analysis by time period 
The risk of MS was significantly higher in all three time windows (explained in Figure 3), and was 
not found to be associated with the date of onset of bipolar disorder, bipolar disorder type I and 
depression (explained in Figure 4), Table 5. The results for schizophrenia were not significant. The 
results remained unchanged when analyzed in the reverse direction. 
 
Sibling cohort—analysis of psychiatric disorders and MS 
The risk of MS in siblings to subjects with bipolar disorder, schizophrenia or depression did not 
differ from the risk in siblings to unexposed individuals, Figure 5. Sibling analyses were performed 
in the reverse direction, with similar results, Table 4. 
 
Sensitivity analysis 
Patients with schizophrenia, defined more widely, with inclusion of cases with additional 
diagnoses of schizoaffective or bipolar disorder, showed no significantly decreased risk of MS (HR 
0.8, 95% CI: 0.7-1.0, p=0.1). To ensure that individuals would be no older than 18 years of age 
when entering the study in 1987 subjects born between 1969 and 1991 were analyzed. The results 
were in agreement with the main results but, in some cases, failed to reach statistical significance, 
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presumably due to lack of power. The outpatient register was started in 2001, which means that 
milder cases of depression might have been included from 2001 and onwards. To avoid selection 
bias, the comorbidity cohort was analyzed with MS as exposure, and the start of follow-up as 2001. 
The increased risk of depression in MS patients remained significant. We also analyzed the effect 
of depression on MS risk, including individuals with a single depression. In total, 303,763 
individuals with depression were identified, and the increased risk of MS remained significant (HR 
2.0 95% CI: 1.9-2.1, p<0.0001). Finally, using diagnostic information from the SMSreg alone and 
in combination with information from the NPR, we obtained similar results as in the main analysis. 
 
Discussion 
 
Comorbidity and familial liability between MS and bipolar disorder, schizophrenia and depression 
were studied in a nationwide Swedish cohort—to our knowledge, the largest study to date of MS 
and psychiatric conditions. A statistically significantly increased risk of comorbid MS was found in 
bipolar disorder and depression, but a significantly decreased risk of MS was found in 
schizophrenia. Compared to risks in unexposed siblings, the risk of MS was not increased in 
siblings to subjects with bipolar disorder, schizophrenia or depression, and the risk of these 
psychiatric disorders was not increased in siblings to MS patients. Our main conclusion is, 
therefore, that the associations between MS and the psychiatric disorders are not confounded by 
familial factors. 
 
There are several strengths in this study: The large study base allowed us to perform analyzes by 
time period and to analyze subcategories such as bipolar disorder type I and severe depression. 
Potential confounders were accounted for by matching for age and sex and the data was analyzed 
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bidirectional. The quality of the MS diagnoses was assured by sensitivity analyses, using MS 
diagnosis from both the NPR and SMSreg. Limitations in our study include the circumstance that 
depression diagnoses in the NPR are not validated. Our lack of access to primary-care register data 
regarding depression may have resulted in a selective bias, in that we may have missed less severe 
cases of depression and therefore underestimated the magnitude of increased risks. However, 
inclusion of patients with a single depression diagnosis did not substantially affect estimates of MS 
risk. We were not able to adjust for socioeconomic status in childhood, but recent data indicate that 
socioeconomic status is not associated with MS (27) and it is not very likely that our results would 
be affected. 
 
The comorbidity between MS and bipolar or depressive disorder were in agreement with previous 
studies in the field (3-14) and may be explained by several hypothetical mechanisms. First, the 
pathogenic events in MS, including the inflammatory process in the CNS, might give rise to 
depressive or even manic symptoms. Second, affective symptoms might be triggered by the 
psychological trauma of having been diagnosed with chronic, disabling disease such as MS. 
However, the analysis of the MS risk by time period revealed no temporal association between the 
occurrence of bipolar disorder or depression and the onset of MS, which argues against the role of 
purely psychological factors, Table 5. Also the increased risk of MS in the severe subgroups 
(bipolar disorder type I and severe depression) suggests involvement of biological mechanisms 
such as inflammation rather than psychological factors. Thirdly, the increased comorbidity could 
be an effect of ascertainment bias; however, the results from the analysis by time period do not 
support this explanation. A fourth possibility is that comorbidity is triggered by MS medications, 
such as interferon beta and corticosteroids, both known to cause psychiatric side effects (28), but 
again the results from the analysis by time period do not support this explanation. According to a 
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fifth possible mechanism, changes in behavior resulting from psychiatric disorders, such as 
increased smoking or reduced exposure to ultraviolet light, might lead to reduced synthesis of 
vitamin D, thus increasing the risk of MS (29). However, the notion that increased MS risk in 
psychiatric conditions is mediated by smoking is not supported by our finding of decreased MS risk 
in schizophrenia, given the high rate of tobacco smoking in patients with schizophrenia, compared 
to rates in the general population (29). We also found gender differences as males with bipolar 
disorder type I were at higher risk of MS compared to females, Table 3. The finding might deserve 
further investigation. 
 
The decreased risk of MS in patients with schizophrenia deviates from the findings of previous 
studies (6, 11, 15-18) and there might be several reasons for the disparate results. The large 
advantage with our data is the population-based approach, the large sample size and the limitation 
to schizophrenia patients who did not exhibit overlap with schizoaffective disorder and bipolar 
disorder. The significant negative association was only seen when no diagnostic overlap was 
allowed, indicating that the results are specific to a particular schizophrenia phenotype lacking 
bipolar affective symptoms. A negative association with schizophrenia has been observed in other 
disorders mediated by inflammation, such as rheumatoid arthritis (30, 31). Like rheumatoid 
arthritis, schizophrenia and MS have been shown to be associated with polymorphisms at human 
leucocyte antigen (32, 33). Although no decreased familial risk was found between MS and 
schizophrenia, it is tempting to speculate that risks conferred by alleles at HLA loci might explain 
part of the negative association between MS and schizophrenia—as has previously been 
demonstrated for DRB1*1501, which is a risk allele in MS and a protective allele in diabetes 
mellitus type 1 (34). Finally protective effects, with regard to MS risk, of treatment with 
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antipsychotic medications or the possibility that patients with severe mental illness have a reduced 
ability to recognize and report symptoms to the healthcare-system, might also explain the findings. 
 
Previous studies found no familial relationship between MS and bipolar disorder or 
depression—which is in accordance with our findings—but an increased risk of schizophrenia has 
been previously reported in patients with a family history of MS (7, 10, 17). Using a method with 
matched sibling controls, we found no significant familial link between MS and schizophrenia. 
 
Conclusion 
 
There is an increased risk of MS in bipolar disorder and depression, including bipolar disorder type 
I and severe depression, and, conversely, an increased risk of these psychiatric conditions in MS 
patients. In contrast to previous findings, in the present study, the risk of MS was found to be 
decreased in patients with schizophrenia, and the risk of schizophrenia decreased in patients with 
MS. However, MS was not found to be underrepresented in siblings to schizophrenic patients, nor 
was schizophrenia found to be underrepresented in siblings to MS patients—findings suggesting 
the involvement of other mechanisms than genetically determined liability. Clinicians should be 
aware of the increased risk of bipolar disorder and depression in patients with MS and pay 
particular attention to neurological symptoms in patients with schizophrenia. 
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Table 1 Diagnostic codes for disease classification according to International Classification of 
Diseases (ICD). 
 
  ICD 8 (1969-1986) ICD 9 (1987-1996) ICD 10 (1997-) 
Bipolar disorder 
a, b
 
296.0-296.3, 296.8, 
296.9 
296.0-296.6, 296.8, 
296.9 
F30.0-F30.2, F30.8, 
F30.9, F31.1-F31.9 
Schizophrenia  
295.0-295.6, 295.8, 
295.9 
295.0-295.6, 295.8, 
295.9 
F20 
Schizoaffective 
disorder 
2957 2957 F25 
Depression
 c
 296.0, 300.4, 298 
296.1, 300.4, 311, 
298.0 
F32, F33 
Multiple sclerosis 340.99 340 G35 
 
a Patients with only one code of bipolar disorder from ICD 8 and ICD 9 were classified as 
bipolar disorder if they had one or more of the following diagnosis (ICD8: 296.0, 296; ICD9: 
2961) 
b Patients who fulfilled the criteria of bipolar disorder and presented at least one of the 
following codes for several manic episodes (ICD8: 296.1; ICD9: 296.0, 296.2, 296.8, ICD10: 
F301, F302, F311, F312) were classified in the subgroup bipolar disorder type I 
c Patients who fulfilled the criteria of depression and presented at least one of the following 
codes for severe depression (ICD8: 296.0, 298; ICD9: 296.1, 298.0; ICD10: F322, F323, 
F332, F333) were classified in the subgroup severe depression 
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Table 2 Characteristics for the patients with psychiatric disorders, multiple sclerosis and their 
siblings 
Psychiatric disorder as exposure and multiple sclerosis as the event 
  Patients with a psychiatric disorder 
Siblings to patients with a 
psychiatric disorder 
  
No of 
patients 
Males/ 
Females 
Age of 
onset in 
years 
a
 
Age of 
onset in 
years - 
born 
1969-
1991
 a
 
Follow-
up time 
in days - 
1987-
2009 
No of 
siblings 
to 
patients 
Males/ 
Females 
Follow-
up time 
in days 
- 1987-
2009 
 
N % 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
N % 
Mean 
(SD) 
All psychotic 
disorders 
71134 48.7/51.3 
37.8 
(12.7) 
26.4 
(6.12) 
7078.8 
(2200.3) 
118374 46.1/50.9 
7227.0 
(2162.1) 
Bipolar disorder 30761 40.4/59.6 
40.0 
(13.3) 
27.0 
(6.3) 
6901.2 
(2352.9) 
51979 39.7/60.3 
6967.5 
(2357.0) 
   Bipolar type I 8695 41.8/58.2 
37.5 
(11.9) 
24.2 
(5.8) 
7185.6 
(2166.7) 
13875 41.9/58.1 
7547.6 
(1882.2) 
Schizophrenia 22781 63.8/36.2 
35.3 
(11.8) 
25.9 
(5.8) 
7116.9 
(2123.8) 
37390 65.5/34.5 
7366.5 
(2034.1) 
Schizo-affective 
disorder 
1816 38.7/61.29 
40.2 
(12.5) 
28.1 
(5.7) 
7104.5 
(2116.7) 
2759 37.9/62.1 
6896.9 
(2328.5) 
Mixed category 15776 44.2/55.8 
34.6 
(10.7) 
24.3 
(5.4) 
7366.9 
(1964.9) 
26246 45.4/54.6 
7577.2 
(1822.8) 
Depression 172479 39.6/60.4 
39.2 
(14.4) 
25.6 
(6.6) 
6682.6 
(2502.5) 
280577 39.6/60.4 
6707.7 
(2504.8) 
Severe 
depression 
48329 40.8/59.2 
40.4 
(13.9) 
25.9 
(6.5) 
6965.2 
(2293.5) 
77849 40.7/59.3 
6903.7 
(2386.0) 
Multiple sclerosis as exposure and psychiatric disorder as the event 
  Patients with multiple sclerosis 
Sibling to patients with 
multiple sclerosis 
  
No of 
patients 
Males/ 
Females 
Age of 
onset in 
years
 a
 
Age of 
onset in 
years - 
born 
1969-
1991
 a
 
Follow-
up time 
in days - 
1973-
2009 
No of 
siblings 
to 
patients 
Males/ 
Females 
Follow-
up time 
in days 
- 1973-
2009 
 
N % 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
N % 
Mean 
(SD) 
All psychotic 
disorders 
16467 30.9/69.1 
43.8 
(11.9) 
28.1 
(5.6) 
10505.4 
(3421.3) 
26506 30.8/69.2 
10429.1 
(3726.5) 
Depression 16446 30.9/69.1 
43.8 
(11.9) 
28.1 
(5.6) 
10320.3 
(3516.9) 
26474 30.8/69.2 
10357.0 
(3751.1) 
a Age of onset defined as age of the first healthcare contact due to the disorder. 
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Table 3 The risk of multiple sclerosis (MS) in patients with psychiatric disorders stratified by 
sex. 
 
 
Risk of MS in patients with PD 
 Sex Patients, n 
(MS 
affected, n) 
HR 95% CI p-value 
All psychotic 
diagnosis 
Male 34,628 (67) 1.24 0.97-1.60 0.0876 
Female 36,506 (182) 1.29 1.11-1.50 0.0008 
Bipolar disorder Male 12,420 (42) 2.31 1.67-3.21 <.0001 
Female 18,341 (111) 1.70 1.40-2.06 <.0001 
  Bipolar type I Male 3631 (23) 4.76 2.94-7.70 <.0001 
Female 5064 (39) 1.76 1.27-2.44 0.0007 
Schizophrenia Male 14,525 (16) 0.71 0.43-1.18 0.1838 
Female 8256 (20) 0.56 0.36-0.88 0.0122 
Depression Male 68,300 (202) 2.20 1.90-2.54 <.0001 
Female 104,179 
(563) 
1.77 1.63-1.92 <.0001 
Severe 
depression 
Male 19,733 (48) 1.84 1.40-2.44 <.0001 
Female 28,596 (137) 1.36 1.15-1.60 0.0003 
Hazard Ratios (HR) and 95% confidence limits (95% CI). The hazard ratios are not adjusted 
for immigration status. 
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Table 4 The risk of psychiatric disorders (PD) in patients with multiple sclerosis (MS) and 
siblings to patients with MS. (MS as exposure and PD as event) 
 
 Risk of PD in patients with MS Risk of PD in siblings to patients with MS 
  Patients, n 
(PD affected, 
n) 
HR 95% 
CI 
p-
value 
Siblings to 
patients, n 
(PD affected, 
n) 
HR 95% 
CI 
p-
value 
All psychotic 
disorders 
16,467 (250) 1.37 1.20-
1.56 
<.0001 26506 (306) 0.96 0.85-
1.08 
0.4665 
Bipolar disorder 16,467 (154) 1.86 1.56-
2.20 
<.0001 26506 (126) 0.93 0.77-
1.11 
0.4157 
  Bipolar type I 16,467 (62) 2.37 1.79-
3.12 
<.0001 26506 (31) 0.77 0.53-
1.10 
0.1513 
Schizophrenia 16,467 (36) 0.71 0.51-
1.00 
0.0478 26506 (93) 0.88 0.71-
1.09 
0.4424 
Schizoaffective 
disorder 
16,467 (3) 0.64 0.20-
2.09 
0.4629 26506 (4) 0.67 0.24-
1.85 
0.0411 
Mixed category 16,467 (57) 1.28 0.97-
1.68 
0.0815 26506 (83) 1.15 0.92-
1.45 
0.2242 
All depression 16,446 (763) 1.86 1.72-
2.01 
<.0001 26474 (681) 1.02 0.95-
1.11 
0.5524 
Severe 
depression 
16,446 (180) 1.52 1.30-
1.78 
<.0001 26474 (191) 0.99 0.85-
1.15 
0.8985 
 
Hazard Ratios (HR) and 95% confidence limits (95% CI). The hazard ratios are not adjusted 
for immigration status. 
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Table 5 Risk of multiple sclerosis (MS) in patients with psychiatric disorders (PD), and risk 
of PD in patients with MS, by time period. 
 
 
Up to 2 years 
prior to date of 
PD onset
a
 
Date of onset of 
PD ±2 years
a
 
2 years after PD 
onset and 
onwards
a
 
From PD onset 
and onwards
b
 
Risk of MS in 
patients with 
PD 
HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
All psychotic 
disorders 
1.63 1.27-2.09 1.73 1.28-2.34 1.16 0.97-1.39 1.10 0.93-1.30 
Bipolar 
disorder 
2.09 1.59-2.74 2.14 1.47-3.11 1.76 1.35-2.30 1.64 1.29-2.08 
  Bipolar type I 6.05 
3.44-
10.63 
2.74 1.31-5.73 1.87 1.32-2.64 1.79 1.29-2.49 
Schizophrenia 0.54 0.22-1.34 0.79 0.34-1.81 0.62 0.41-0.95 0.55 0.37-0.84 
All depression 2.01 1.79-2.27 2.63 2.27-3.04 1.86 1.62-2.12 1.51 1.35-1.69 
  Severe 
depression 
1.32 1.03-1.70 2.30 1.76-3.00 1.68 1.31-2.14 1.33 1.08-1.64 
Risk of PD in 
patients with 
MS 
HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
 
Up to 2 years 
prior to date of 
MS onset
a
 
Date of onset of 
MS ±2 years
a
 
2 years after MS 
onset and 
onwards
a
 
From MS onset 
and onwards
b
 
All psychotic 
disorders 
1.38 1.20-1.58 1.74 1.28-2.36 1.61 1.25-2.08 1.74 1.41-2.15 
Bipolar 
disorder 
1.82 1.52-2.18 1.98 1.35-2.89 1.93 1.45-2.57 2.08 1.63-2.65 
  Bipolar type I 2.25 1.69-3.01 2.76 1.25-6.12 4.93 2.69-9.05 4.76 2.85-7.97 
Schizophrenia 0.73 0.51-1.02 0.91 0.39-2.11 0.74 0.32-1.70 0.89 0.48-1.65 
All depression 1.53 1.33-1.76 2.78 2.39-3.22 1.80 1.58-2.04 2.13 1.93-2.36 
  Severe 
depression 
1.44 1.11-1.88 2.72 2.07-3.59 1.08 0.81-1.44 1.55 1.25-1.92 
 
Hazard Ratios (HR) and 95% confidence limits (95% CI). Significant HRs are indicated by 
bold text. The hazard ratios are not adjusted for immigration status. 
a Analysis as described in Figure 3 
b Analysis as described in Figure 4 
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Figure legends 
 
Figure 1 Flowchart of the study population in the comorbidity and the sibling cohorts 
(psychiatric disorders as exposure and multiple sclerosis as outcome). 
 
Figure 2 Flowchart of the study population in the comorbidity and the sibling cohorts (multiple 
sclerosis as exposure and psychiatric disorders as outcome). 
 
Figure 3 Analysis by time period of multiple sclerosis (MS) risk in the comorbidity cohort with 
psychiatric disorder (PD) as exposure: 
MS risk was analyzed: A) from entry date until two years before date of PD onset; B) from two 
years before until 2 years after date of PD onset; C) from two years after date of PD onset until 
end of follow-up. The analyses were performed in a reverse manner, whereby PD risk was 
analyzed with MS as exposure. 
 
Figure 4 MS risk was analyzed after date of onset (entry date) of the psychiatric disorder (PD), 
until an event occurred or the subject was censored. Patients with an MS event before entry date 
were censored. The analyses were performed in a reverse manner, whereby PD risk was analyzed 
with MS as exposure. 
 
Figure 5 Boxplot showing the risk of multiple sclerosis (MS) in patients with a psychiatric 
disorder and in siblings to patients with a psychiatric disorder. HR = hazard ratio; CI = 
confidence interval. The hazard ratios are not adjusted for immigration status. 
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Figure 1 Flowchart of the study population in the comorbidity and the sibling cohorts (psychiatric disorders 
as exposure and multiple sclerosis as outcome).  
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Figure 2 Flowchart of the study population in the comorbidity and the sibling cohorts (multiple sclerosis as 
exposure and psychiatric disorders as outcome).  
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Figure 3 Analysis by time period of multiple sclerosis (MS) risk in the comorbidity cohort with psychiatric 
disorder (PD) as exposure:  
MS risk was analyzed: A) from entry date until two years before date of PD onset; B) from two years before 
until 2 years after date of PD onset; C) from two years after date of PD onset until end of follow-up. The 
analyses were performed in a reverse manner, whereby PD risk was analyzed with MS as exposure.  
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Figure 4 MS risk was analyzed after date of onset (entry date) of the psychiatric disorder (PD), until an 
event occurred or the subject was censored. Patients with an MS event before entry date were censored. 
The analyses were performed in a reverse manner, whereby PD risk was analyzed with MS as exposure.  
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Figure 5 Boxplot showing the risk of multiple sclerosis (MS) in patients with a psychiatric disorder and in 
siblings to patients with a psychiatric disorder. HR = hazard ratio; CI = confidence interval. The hazard 
ratios are not adjusted for immigration status.  
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